Which companies overlap with Clinique Spécialisée en Allergies de la Capitale's portfolio?

Top competitors by shared drug class: ALK-Abelló A/S, HAL Allergy, Laboratorios Leti, S.L., Medical University of Lodz.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/clinique-sp-cialis-e-en-allergies-de-la-capitale.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Clinique Spécialisée en Allergies de la Capitale — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinique Spécialisée en Allergies de la Capitale pipeline: 4 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
HDM 12 SQ-HDM	HDM 12 SQ-HDM	marketed	Allergen immunotherapy (sublingual tablet)	House dust mite allergens (Der p 1, Der p 2, Der f 1, Der f 2)	Immunology / Allergy
tree 12 SQ-Bet	tree 12 SQ-Bet	marketed	Allergen immunotherapy (sublingual tablet)	Tree pollen allergens (IgE cross-linking epitopes)	Immunology / Allergy
RAGWEED 12 AMB A 1-U	RAGWEED 12 AMB A 1-U	marketed	Allergen extract immunotherapy	Ragweed pollen allergens (Amb a 1 and related epitopes)	Immunology / Allergy
GRASS 2800 BAU	GRASS 2800 BAU	marketed	Allergen immunotherapy extract	Grass pollen allergens (Poa pratensis, Lolium perenne, and other grass species)	Immunology / Allergy

Therapeutic area mix

Immunology / Allergy · 4

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ALK-Abelló A/S · 1 shared drug class
HAL Allergy · 1 shared drug class
Laboratorios Leti, S.L. · 1 shared drug class
Medical University of Lodz · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Clinique Spécialisée en Allergies de la Capitale:

Cite this brief

Drug Landscape (2026). Clinique Spécialisée en Allergies de la Capitale — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/clinique-sp-cialis-e-en-allergies-de-la-capitale. Accessed 2026-05-17.